BRAF inhibitor
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
BRAF inhibitor
Mar 3, 2024, 17:02 |
Insight
Aaron Goodman: Patients with Erdheim Chester disease should be started on much lower doses of targeted therapies
Aaron Goodman shared an X post by Razelle Kurzrock, Associate Director of Clinical Research for…
Feb 25, 2024, 15:01 |
Insight
Arndt Vogel: Impressive and comprehensive review on BRAF mutations
Arndt Vogel shared on X/Twitter: "BRAF — a tumor-agnostic drug target with lineage-specific dependencies. Impressive…
Feb 23, 2024, 17:40 |
Drugs
Nicole Verdun: We granted accelerated approval for Amtagvi (lifileucel), manufactured by Iovance Biotherapeutics
Nicole Verdun, Super Office Director at FDA, recently posted on LinkedIn: "I am pleased to…
All:
3
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube